Skip to main content
FinSpry Logo
FinSpry
IDXX logo
IDXX
(NASDAQ)
IDEXX Laboratories, Inc.
$539.37-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

IDEXX Laboratories (IDXX) Stock Price & Financial Analysis

IDEXX Laboratories Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$534.36 - $547.61
52-Week High$769.98
52-Week Low$518.55
Open$542.17
Volume459.35K
Average Volume (3M)671.73K
Market Cap43.51B
Shares Outstanding80.67M
P/E Ratio (TTM)39.73
Forward P/E32.50
Price to Sales (P/S)9.79
Price to Book (P/B)27.96
EV/EBITDA28.51
Revenue (TTM)4.45B
Net Income (TTM)1.10B
Free Cash Flow (TTM)1.08B
EPS (TTM)$13.56
Profit Margin24.63%
Operating Margin31.63%
Return on Equity (ROE)70.38%
Debt to Equity0.71
50-Day MA$554.28
200-Day MA$622.53
52-Week Change-0.24%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About IDEXX Laboratories

What is the current stock price for IDXX?

As of the latest trading session, IDXX stock trades at $539.37. The 52-week range is $518.55–$769.98, with a day range of $534.36–$547.61.

What is the P/E ratio for IDXX?

IDEXX Laboratories's trailing P/E ratio is 39.7, meaning investors pay $39.7 for every $1 of annual earnings. The forward P/E is 32.5, reflecting analyst expectations for future earnings. IDEXX Laboratories operates in the Healthcare sector.

Does IDXX pay dividends?

IDEXX Laboratories does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IDXX?

Based on 6 analysts, the consensus for IDXX is Buy.

What is the market cap of IDXX?

IDEXX Laboratories's market capitalization is $43.51B, classifying it as a large-cap company. IDEXX Laboratories operates in the Healthcare sector within the Diagnostics & Research industry.